iHeart Japan Corporation

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
iHeart Japan is developing allogeneic regenerative medicinal products derived from iPS cells, and selling research tools for cardiotoxicity and efficacy. The base technology was invented by Prof. Jun Yamashita of Kyoto Univ. Center of iPSC Research and Application.
Company Type:
Company HQ State:
Not Provided
Company HQ Country:
Japan
Year Founded:
2013
Main Therapeutic Focus:
Lead Product in Development:
IHJ-301(iPSC-derived multilayered cardiac cell sheets)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2
Speaker
photo
President and CEO
iHeart Japan Corporation